Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (201-210 of 310) with videos related to

Pageof 31
Sort By:
Nature Methods|March 31, 2025
Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagementIno de Bruijn, Milen Nikolov, Clarisse Lau, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Cancer Discovery|June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapyHikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Extracellular matrix regulates lineage plasticity in prostate cancer through YAP/TEADTeng Han, Zhen Sun, Matthew Lange, et al.
Cancer Discovery|October 18, 2023
Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerSarah P Suehnholz, Moriah H Nissan, Hongxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancerMichael B Foote, Guilherme Harada, Somer Abdelfattah, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Nature Medicine|August 15, 2024
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolismJustin Jee, A Rose Brannon, Rohan Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate CancerGoutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, et al.
Pageof 31

Showing results (201-210 of 310) with videos related to

Sort By:
Pageof 31
Nature Methods|March 31, 2025
Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagementIno de Bruijn, Milen Nikolov, Clarisse Lau, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Cancer Discovery|June 18, 2014
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapyHikmat Al-Ahmadie, Gopa Iyer, Marcel Hohl, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Extracellular matrix regulates lineage plasticity in prostate cancer through YAP/TEADTeng Han, Zhen Sun, Matthew Lange, et al.
Cancer Discovery|October 18, 2023
Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerSarah P Suehnholz, Moriah H Nissan, Hongxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancerMichael B Foote, Guilherme Harada, Somer Abdelfattah, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Nature Medicine|August 15, 2024
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolismJustin Jee, A Rose Brannon, Rohan Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2022
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate CancerGoutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, et al.
Pageof 31